Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer.

Published
February 06, 2024
Journal
NEJM evidence
PICOID
c2941843
DOI
Citations
5
Keywords
Copyright
Patients/Population/Participants

advanced prostate cancer

Intervention

surrogate end points

Comparison

overall survival

Outcome

may not track

Abstract

P
I
C
O

Meta-Analysis of Surrogate End Points in Prostate CancerGharzai et al. report on the results of a meta-analysis, which concludes that unlike the case in localized prostate cancer, surrogate end points in advanced prostate cancer may not track overall survival.

Similar article map

CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.